1 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in CVD and CKD ... in HFrEF on GDMT ... outcomes in HFrEF ... #inhibitors #EBM ... #table #CVD #CKD